Michael Goldstein's most recent trade in Tucows, Inc. - Ordinary Shares - Class A was a trade of 2,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 63,333 | 313,335 (0%) | 0% | 0 | Common Stock | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 02 Dec 2021 | 2,500 | 5,282 (0%) | 0% | 19.4 | 48,525 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.93 per share. | 24 Jun 2021 | 1,600 | 2,782 (0%) | 0% | 15.9 | 25,488 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 1,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |